{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P04626",
      "entity_text" : "HER2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0595" ],
      "Cellular_component" : [ "uniprot:SL-0039" ]
    }
  },
  "verbose_text" : "Breast cancer cells expressing different levels of the HER2 / neu receptors were pretreated with biotinylated Herceptin, followed by nanoparticles targeted to the receptors.",
  "reading_complete" : "2020-08-02T17:44:40Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T17:36:34Z",
  "trigger" : "levels",
  "evidence" : [ "levels of the HER2" ],
  "pmc_id" : "3263514",
  "score" : 0
}